Rheumatoid Arthritis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067357
  • December 2021
  • Pharmaceuticals
  • 254 Pages
Report Description

This report is a comprehensive study that examines the Rheumatoid Arthritis industry in depth. With reference to key regions and major nations, the study specifies the product type of Rheumatoid Arthritis as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Rheumatoid Arthritis market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Rheumatoid Arthritis market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Rheumatoid Arthritis market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Rheumatoid Arthritis Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Rheumatoid Arthritis market study. The market dynamics and factors such as the threat of a Rheumatoid Arthritis substitute, the threat of new entrants into the Rheumatoid Arthritis market, buyer bargaining power, supplier bargaining power to Rheumatoid Arthritis providing companies, and internal rivalry among Rheumatoid Arthritis providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Rheumatoid Arthritis market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Rheumatoid Arthritis industry.
 
Rheumatoid Arthritis Market Key Trends Analysis

The important factors influencing the growth of the Rheumatoid Arthritis market have been examined in this report. The driving factors that are boosting demand for Rheumatoid Arthritiss and the restraining factors that are slowing growth of the Rheumatoid Arthritis industry are addressed in depth, as well as their implications for the worldwide Rheumatoid Arthritis market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Rheumatoid Arthritis Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Rheumatoid Arthritis industry. On the basis of current and future trends, all segments of the Rheumatoid Arthritis industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Rheumatoid Arthritis Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Rheumatoid Arthritis market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Rheumatoid Arthritis market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Rheumatoid Arthritis market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Rheumatoid Arthritis market. All important stakeholders in the Rheumatoid Arthritis value chain and technological ecosystem are expected to benefit from the insights offered in the Rheumatoid Arthritis market research study.

In order to provide a broader understanding of the top competitors in the Rheumatoid Arthritis market, the research includes a company market share analysis. Merck KGaA, Sanofi, Eli Lilly Company, Amgen Inc., Bristol-Mayor Squibb, F. Hoffman-La Roche Ltd., Johnson & Johnson, Cipla, Pfizer, Galapagos NV, Gilead Sciences. are among the major participants in the global Rheumatoid Arthritis industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Merck KGaA, Sanofi, Eli Lilly Company, Amgen Inc., Bristol-Mayor Squibb, F. Hoffman-La Roche Ltd., Johnson & Johnson, Cipla, Pfizer, Galapagos NV, Gilead Sciences.
 
Major Highlights of the Rheumatoid Arthritis Market report study:
  • An in-depth examination of the global Rheumatoid Arthritis industry will be published soon.
  • The study examines the global Rheumatoid Arthritis market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Rheumatoid Arthritis industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Rheumatoid Arthritis market is being shaped by several major trends.
  • The size of the Rheumatoid Arthritis market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Rheumatoid Arthritis market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Rheumatoid Arthritis market as follows:
Global Rheumatoid Arthritis Market: By Product Type

  • NSAIDs
  • DMARDs
  • Corticosteroids
  • Others

Global Rheumatoid Arthritis Market: By Application
  • Application I
  • Application II
  • Application III

Global Rheumatoid Arthritis Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Rheumatoid Arthritis market.
  • Universities and students
  • Other companies in the Rheumatoid Arthritis market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Rheumatoid Arthritis market

Manufacturers and Segments

  • Merck KGaA
  • Sanofi
  • Eli Lilly Company
  • Amgen Inc.
  • Bristol-Mayor Squibb
  • F. Hoffman-La Roche Ltd.
  • Johnson & Johnson
  • Cipla
  • Pfizer
  • Galapagos NV
  • Gilead Sciences.
  • NSAIDs
  • DMARDs
  • Corticosteroids
  • Others
  • Application I
  • Application II
  • Application III

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Rheumatoid Arthritis Market Snapshot
          2.1.1. Global Rheumatoid Arthritis Market By NSAIDs,2019
               2.1.1.1.
               2.1.1.2.NSAIDs
               2.1.1.3.DMARDs
               2.1.1.4.Corticosteroids
          2.1.2. Global Rheumatoid Arthritis Market By Application I,2019
               2.1.2.1.
               2.1.2.2.Application I I
               2.1.2.3.Application I II
          2.1.3. Global Rheumatoid Arthritis Market By End-use,2019
          2.1.4. Global Rheumatoid Arthritis Market By Geography,2019

3. Global Rheumatoid Arthritis Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By NSAIDs, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By NSAIDs, 2020
     4.2. Global Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028

5. Global Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application I, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application I, 2020
     5.2. Global Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028

6. Global Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028

7. Global Rheumatoid Arthritis Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Rheumatoid Arthritis Market Analysis, 2018 – 2028 
          7.2.1. North America Rheumatoid Arthritis Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028
          7.2.3. North America Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028
          7.2.4. North America Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Rheumatoid Arthritis Market Analysis, 2018 – 2028 
          7.3.1.  Europe Rheumatoid Arthritis Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028
          7.3.3. Europe Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028
          7.3.4. Europe Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Rheumatoid Arthritis Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Rheumatoid Arthritis Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028
          7.4.3. Asia Pacific Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028
          7.4.4. Asia Pacific Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Rheumatoid Arthritis Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Rheumatoid Arthritis Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028
          7.5.3. Latin America Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028
          7.5.4. Latin America Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Rheumatoid Arthritis Market Analysis, 2018 – 2028 
          7.6.1.  MEA Rheumatoid Arthritis Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Rheumatoid Arthritis Market Size (US$), By NSAIDs, 2018 – 2028
          7.6.3. MEA Rheumatoid Arthritis Market Size (US$), By Application I, 2018 – 2028
          7.6.4. MEA Rheumatoid Arthritis Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Rheumatoid Arthritis Providers
        8.4.1 Merck KGaA
                8.4.1.1 Business Description
                8.4.1.2 Merck KGaA Geographic Operations
                8.4.1.3 Merck KGaA Financial Information
                8.4.1.4 Merck KGaA Product Positions/Portfolio
                8.4.1.5 Merck KGaA Key Developments
        8.4.2 Sanofi
                8.4.2.1 Business Description
                8.4.2.2 Sanofi Geographic Operations
                8.4.2.3 Sanofi Financial Information
                8.4.2.4 Sanofi Product Positions/Portfolio
                8.4.2.5 Sanofi Key Developments
        8.4.3 Eli Lilly Company
                8.4.3.1 Business Description
                8.4.3.2 Eli Lilly Company Geographic Operations
                8.4.3.3 Eli Lilly Company Financial Information
                8.4.3.4 Eli Lilly Company Product Positions/Portfolio
                8.4.3.5 Eli Lilly Company Key Developments
        8.4.4 Amgen Inc.
                8.4.4.1 Business Description
                8.4.4.2 Amgen Inc. Geographic Operations
                8.4.4.3 Amgen Inc. Financial Information
                8.4.4.4 Amgen Inc. Product Positions/Portfolio
                8.4.4.5 Amgen Inc. Key Developments
        8.4.5 Bristol-Mayor Squibb
                8.4.5.1 Business Description
                8.4.5.2 Bristol-Mayor Squibb Geographic Operations
                8.4.5.3 Bristol-Mayor Squibb Financial Information
                8.4.5.4 Bristol-Mayor Squibb Product Positions/Portfolio
                8.4.5.5 Bristol-Mayor Squibb Key Developments
        8.4.6 F. Hoffman-La Roche Ltd.
                8.4.6.1 Business Description
                8.4.6.2 F. Hoffman-La Roche Ltd. Geographic Operations
                8.4.6.3 F. Hoffman-La Roche Ltd. Financial Information
                8.4.6.4 F. Hoffman-La Roche Ltd. Product Positions/Portfolio
                8.4.6.5 F. Hoffman-La Roche Ltd. Key Developments
        8.4.7 Johnson & Johnson
                8.4.7.1 Business Description
                8.4.7.2 Johnson & Johnson Geographic Operations
                8.4.7.3 Johnson & Johnson Financial Information
                8.4.7.4 Johnson & Johnson Product Positions/Portfolio
                8.4.7.5 Johnson & Johnson Key Developments
        8.4.8 Cipla
                8.4.8.1 Business Description
                8.4.8.2 Cipla Geographic Operations
                8.4.8.3 Cipla Financial Information
                8.4.8.4 Cipla Product Positions/Portfolio
                8.4.8.5 Cipla Key Developments
        8.4.9 Pfizer
                8.4.9.1 Business Description
                8.4.9.2 Pfizer Geographic Operations
                8.4.9.3 Pfizer Financial Information
                8.4.9.4 Pfizer Product Positions/Portfolio
                8.4.9.5 Pfizer Key Developments
        8.4.10 Galapagos NV
                8.4.10.1 Business Description
                8.4.10.2 Galapagos NV Geographic Operations
                8.4.10.3 Galapagos NV Financial Information
                8.4.10.4 Galapagos NV Product Positions/Portfolio
                8.4.10.5 Galapagos NV Key Developments
        8.4.11 Gilead Sciences.
                8.4.11.1 Business Description
                8.4.11.2 Gilead Sciences. Geographic Operations
                8.4.11.3 Gilead Sciences. Financial Information
                8.4.11.4 Gilead Sciences. Product Positions/Portfolio
                8.4.11.5 Gilead Sciences. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Rheumatoid Arthritis Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Rheumatoid Arthritis Market Revenue, By NSAIDs, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Rheumatoid Arthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Rheumatoid Arthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Rheumatoid Arthritis Market Revenue, By NSAIDs, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Rheumatoid Arthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Rheumatoid Arthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Rheumatoid Arthritis Market Revenue, By NSAIDs, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Rheumatoid Arthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Rheumatoid Arthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Rheumatoid Arthritis Market Revenue, By NSAIDs, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Rheumatoid Arthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Rheumatoid Arthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Rheumatoid Arthritis Market Revenue, By NSAIDs, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Rheumatoid Arthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Rheumatoid Arthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Rheumatoid Arthritis: Market Segmentation 
FIG. 2 Global Rheumatoid Arthritis Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Rheumatoid Arthritis Market, By NSAIDs, 2019 (US$ Mn) 
FIG. 5 Global Rheumatoid Arthritis Market, By Application I, 2019 (US$ Mn) 
FIG. 6 Global Rheumatoid Arthritis Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Rheumatoid Arthritis Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Rheumatoid Arthritis Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Rheumatoid Arthritis Providers, 2019
FIG. 11 Global Rheumatoid Arthritis Market Revenue Contribution, By NSAIDs, 2019 & 2028 (Value %) 
FIG. 12 Global Rheumatoid Arthritis Market Revenue Contribution, By Application I, 2019 & 2028 (Value %) 
FIG. 13 Global Rheumatoid Arthritis Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Rheumatoid Arthritis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Rheumatoid Arthritis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Rheumatoid Arthritis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Rheumatoid Arthritis Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Rheumatoid Arthritis Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Rheumatoid Arthritis market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Rheumatoid Arthritis Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Rheumatoid Arthritis Market Value, By Segment1, 2018 – 2028
TABLE  North America Rheumatoid Arthritis Market Value, By Segment2, 2018 – 2028
TABLE  North America Rheumatoid Arthritis Market Value, By Country, 2018 – 2028
TABLE  Europe Rheumatoid Arthritis Market Value, By Segment1, 2018 – 2028
TABLE  Europe Rheumatoid Arthritis Market Value, By Segment2, 2018 – 2028
TABLE  Europe Rheumatoid Arthritis Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Rheumatoid Arthritis Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Rheumatoid Arthritis Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Rheumatoid Arthritis Market Value, By Country, 2018 – 2028
TABLE  Latin America Rheumatoid Arthritis Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Rheumatoid Arthritis Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Rheumatoid Arthritis Market Value, By Country, 2018 – 2028
TABLE  MEA Rheumatoid Arthritis Market Value, By Segment1, 2018 – 2028
TABLE  MEA Rheumatoid Arthritis Market Value, By Segment2, 2018 – 2028
TABLE  MEA Rheumatoid Arthritis Market Value, By Country, 2018 – 2028
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Mayor Squibb: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffman-La Roche Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Galapagos NV: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Rheumatoid Arthritis Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Rheumatoid Arthritis Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Rheumatoid Arthritis Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Rheumatoid Arthritis Market, By Geography, 2019 (US$ Mn)
FIG.  Global Rheumatoid Arthritis Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Rheumatoid Arthritis Providers, 2016
FIG.  Global Rheumatoid Arthritis Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global NSAIDs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global DMARDs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Corticosteroids Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Rheumatoid Arthritis Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Application I Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application II Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application III Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Rheumatoid Arthritis Market Value, 2018 – 2028, (US$ Mn)